Doctors

Participants receiving the potent and highly selective BTK inhibitor fenebrutinib maintained low disease activity in the OLE of the FENopta...

Research presented at ACC.25 focused on coordination teams and new hospital workflows designed to improve referrals and care quality for...

Participants in the novel EAFToS study had high adherence rates to initiation and maintenance doses of ofatumumab in the first...

The post-approval safety profile of cladribine tablets in relapsing MS was updated, with results consistent with development program findings and...

Researchers found that higher ocrelizumab exposure over 10 years was associated with less risk of disability progression in patients with...

Using the 2024 McDonald Criteria revisions around 30% of patients with atypical clinical symptoms or radiological-only presentation meet MS diagnostic...

The following is a summary of “Trabecular texture and paraspinal muscle characteristics for prediction of first vertebral fracture: a QCT...

The following is a summary of “Efficacy of NSAIDs in reducing pain during intrauterine device Insertion: A systematic review,” published...

The post Una Vida Saludable Con Esclerosis Multiple (Healthy Living With Multiple Sclerosis – Spring/Summer 2025) first appeared on Physician's...

The following is a summary of “Nonlinear association of cardiometabolic index with hyperuricemia: insights from the NHANES 1999-2018 study,” published...